Journal of Clinical Endocrinology & Metabolism, Vol 81, 1179-1183, Copyright © 1996 by Endocrine Society

ARTICLES

Growth hormone does not increase thyroid size in the absence of thyrotropin: a study in adults with hypopituitarism

NW Cheung, JC Lou and SC Boyages
Department of Clinical Endocrinology, Westmead Hospital, Sydney, Australia.

Goiter is a frequent clinical finding in patients with acromegaly, an effect mediated by chronically elevated insulin-like growth factor I (IGF-I) levels. It is unclear, however, whether the presence of TSH is a prerequisite for the growth-promoting actions of IGF-I on the human thyroid. We, therefore, studied a group of subjects with hypopituitarism, who were deficient in both TSH and GH, examining the effects of GH replacement therapy on thyroid size and function. GH replacement was initiated in 14 subjects with hypopituitarism. After 6 months of recombinant human GH therapy at 0.25 IU/ kg week, IGF-I levels increased from 11.5 +/- 6.0 to 32.4 +/- 15.4 nmol/L (P = 0.002). Thyroid volume, as determined by ultrasound, did not change significantly over this period. Similarly, there was no change in thyroglobulin levels after treatment with GH, but there was a decrease in the free T4/free T3 ratio (P = 0.043). Pretreatment thyroid size in subjects with hypopituitarism was also compared to that in a group of age- and sex-matched controls. The size of thyroid glands in the hypopituitarism group was smaller than that in controls (P = 0.015). We found that GH therapy did not increase thyroid size in patients with hypopituitarism. From these data we conclude that in vivo, IGF-I does not independently stimulate thyroid growth, but promotes thyroid cell proliferation by potentiating the mitogenic action of TSH.

This article has been cited by other articles:

				T. Fukushima, T. Nedachi, H. Akizawa, M. Akahori, F. Hakuno, and S.-I. Takahashi Distinct Modes of Activation of Phosphatidylinositol 3-Kinase in Response to Cyclic Adenosine 3', 5'-Monophosphate or Insulin-Like Growth Factor I Play Different Roles in Regulation of Cyclin D1 and p27Kip1 in FRTL-5 Cells Endocrinology, July 1, 2008; 149(7): 3729 - 3742. [Abstract] [Full Text] [PDF]

				H. Volzke, N. Friedrich, S. Schipf, R. Haring, J. Ludemann, M. Nauck, M. Dorr, G. Brabant, and H. Wallaschofski Association between Serum Insulin-Like Growth Factor-I Levels and Thyroid Disorders in a Population-Based Study J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4039 - 4045. [Abstract] [Full Text] [PDF]

				M. R. S. Alcantara, R. Salvatori, P. R. S. Alcantara, L. M. A. Nobrega, V. S. Campos, E. C. O. Oliveira, M. H. S. Oliveira, A. H. O. Souza, and M. H. Aguiar-Oliveira Thyroid Morphology and Function in Adults with Untreated Isolated Growth Hormone Deficiency J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 860 - 864. [Abstract] [Full Text] [PDF]

				M. De Felice, M. P. Postiglione, and R. Di Lauro Minireview: Thyrotropin Receptor Signaling in Development and Differentiation of the Thyroid Gland: Insights from Mouse Models and Human Diseases Endocrinology, September 1, 2004; 145(9): 4062 - 4067. [Full Text] [PDF]

				K. B. Markou, P. Paraskevopoulou, K. S. Karaiskos, M. Makri, N. A. Georgopoulos, G. Iconomou, C. Mengreli, and A. G. Vagenakis Hyperthyrotropinemia during Iodide Administration in Normal Children and in Children Born with Neonatal Transient Hypothyroidism J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 617 - 621. [Abstract] [Full Text] [PDF]

				S. Clement, S. Refetoff, B. Robaye, J. E. Dumont, and S. Schurmans Low TSH Requirement and Goiter in Transgenic Mice Overexpressing IGF-I and IGF-I Receptor in the Thyroid Gland Endocrinology, December 1, 2001; 142(12): 5131 - 5139. [Abstract] [Full Text] [PDF]

				T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models Endocr. Rev., October 1, 2001; 22(5): 631 - 656. [Abstract] [Full Text] [PDF]

				A. Van Keymeulen, S. Deleu, J. Bartek, J. E. Dumont, and P. P. Roger Respective Roles of Carbamylcholine and Cyclic Adenosine Monophosphate in Their Synergistic Regulation of Cell Cycle in Thyroid Primary Cultures Endocrinology, March 1, 2001; 142(3): 1251 - 1259. [Abstract] [Full Text] [PDF]

				T. Nedachi, M. Akahori, M. Ariga, H. Sakamoto, N. Suzuki, K. Umesaki, F. Hakuno, and S.-I. Takahashi Tyrosine Kinase and Phosphatidylinositol 3-Kinase Activation Are Required for Cyclic Adenosine 3',5'-Monophosphate-Dependent Potentiation of Deoxyribonucleic Acid Synthesis Induced by Insulin-Like Growth Factor-I in FRTL-5 Cells Endocrinology, July 1, 2000; 141(7): 2429 - 2438. [Abstract] [Full Text] [PDF]